No Influence of Exogenous Hyaluronan on the Behavior of Human Cancer Cells or Endothelial Cell Capillary Formation

Journal of Food Science

Volumn 79, Issue 7, 2014, Pages

  Seino, Satoshi ^a,b   Takeshita, Fumitaka ^a   Asari, Akira ^c,d,e   Masuda, Yasunobu ^b   Kunou, Masaaki ^b   Ochiya, Takahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KEWPIE CORPORATION   (Japan)

^c Hyaluronan Research Institute Inc   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; Food safety; Functional food; Hyaluronan; Polysaccharides

Indexed keywords

ANIMALIA; MUS;

HYALURONIC ACID;

ANIMAL; CELL LINE; CELL MOTION; CELL PROLIFERATION; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; MALE; METABOLISM; MOLECULAR WEIGHT; MOUSE; NEOVASCULARIZATION (PATHOLOGY); TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; HYALURONIC ACID; MALE; MICE; MOLECULAR WEIGHT; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84904341626     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/1750-3841.12500     Document Type: Article

References (35)

1. Arai E, Nishida Y, Wasa J, Urakawa H, Zhuo L, Kimata K, Kozawa E, Futamura N, Ishiguro N. 2011. Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo. Br J Cancer 105:1839-49.
2. Aruga F, Miwa Y, Fuzimura T, Ohta S. 1992. Micronucleus test of sodium hyaluronate (SH) with mice. Jpn Pharmacol Ther 20:775-7.
3. Asari A, Kanemitsu T, Kurihara H. 2010. Oral administration of high molecular weight hyaluronan (900 kDa) controls immune system via Toll-like receptor 4 in the intestinal epithelium. J Biol Chem 285:24751-8.
4. Asari A, Miyauchi S, Miyazaki K, Hamai A, Horie K, Takahashi T, Sekiguchi T, Machida A, Kohno K, Uchiyama Y. 1992. Intra- and extracellular localization of hyaluronic acid and proteoglycan constituents (chondroitin sulfate, keratan sulfate, and protein core) in articular cartilage of rabbit tibia. J Histochem Cytochem 40:1693-703.
5. Balogh L, Polyak A, Mathe D, Kiraly R, Thuroczy J, Terez M, Janoki G, Ting Y, Bucci LR, Schauss AG. 2008. Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs. J Agric Food Chem 56:10582-93.
6. Bourguignon LYW, Wong G, Earle CA, Xia W. 2011. Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion. Cytoskeleton 68:671-93.
7. Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420:860-7.
8. Hagiwara K, Kosaka N, Yoshioka Y, Takahashi R-U, Takeshita F, Ochiya T. 2012. Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity. Sci Rep 2:314.
9. Hill DR, Kessler SP, Rho HK, Cowman MK, de la Motte CA. 2012. Specific-sized hyaluronan fragments promote expression of human β-defensin 2 in intestinal epithelium. J Biol Chem 287:30610-24.
10. Hirose Y, Saijou E, Sugano Y, Takeshita F, Nishimura S, Nonaka H, Chen Y-R, Sekine K, Kido T, Nakamura T, Kato S, Kanke T, Nakamura K, Nagai R, Ochiya T, Miyajima A. 2012. Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis. Proc Natl Acad Sci USA 109:4263-8.
11. Hosono K, Nishida Y, Knudson W, Knudson CB, Takahiro N, Yoshitaka S, Naoki I, Naruse T, Suzuki Y, Ishiguro N. 2007. Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells. Am J Pathol 171:274-86.
12. Itano N, Zhuo L, Kimata K. 2008. Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression. Cancer Sci 99:1720-5.
13. Kosaka N, Iguchi H, Hagiwara K, Yoshioka Y, Takeshita F, Ochiya T. 2013. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem 288:10849-59.
14. Laznicek M, Laznickova A, Cozikova D, Velebny V. 2012. Preclinical pharmacokinetics of radiolabelled hyaluronan. Pharmacol Rep 64:428-37.
15. Li Y, Li L, Brown TJ, Heldin P. 2007. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Intl J Cancer 120:2557-67.
16. Liu N, Gao F, Han Z, Xu X, Underhill CB, Zhang L. 2001. Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Res 61:5207-14.
17. Ma J, Granton P V, Holdsworth DW, Turley EA. 2013. Oral administration of hyaluronan reduces bone turnover in ovariectomized rats. J Agric Food Chem 61:339-45.
18. Matsumoto K, Li Y, Jakuba C, Sugiyama Y, Sayo T, Okuno M, Dealy CN, Toole BP, Takeda J, Yamaguchi Y, Kosher RA. 2009. Conditional inactivation of Has2 reveals a crucial role for hyaluronan in skeletal growth, patterning, chondrocyte maturation and joint formation in the developing limb. Development 136:2825-35.
19. Meyer K, Palmer JW. 1934. The polysaccharide of the vitreous humor. J Biol Chem 107:629-34.
20. Mo W, Yang C, Liu Y, He Y, Wang Y, Gao F. 2011. The influence of hyaluronic acid on vascular endothelial cell proliferation and the relationship with ezrin / merlin expression. Acta Biochem Biophys Sinica 43:930-9.
21. Mueller BM, Schraufstatter IU, Goncharova V, Povaliy T, Discipio R, Khaldoyanidi SK. 2010. Hyaluronan inhibits postchemotherapy tumor regrowth in a colon carcinoma xenograft model. Mol Cancer Ther 9:3024-32.
22. Oe M, Yoshida T, Kanemitsu T, Matsuoka R, Masuda Y. 2011. Repeated 28-day oral toxicological study of hyaluronic acid in rats. Pharmacometrics (oyo yakuri) 81:11-21.
23. Onishi M, Nagata T, Saigou K, Sameshima H, Nagata R. 1992. Mutagenicity studies of sodium hyaluronate (SH). Jpn Pharmacol Ther 20:767-74.
24. Shay E, He H, Sakurai S, Tseng SCG. 2011. Inhibition of angiogenesis by HC.HA, a complex of hyaluronan and the heavy chain of inter-α-inhibitor, purified from human amniotic membrane. Invest Ophthalmol Vis Sci 52:2669-78.
25. Smedsrød B, Pertoft H, Eriksson S, Fraser JRE, Laurent TC. 1984. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J 223:617-26.
26. Sohara Y, Ishiguro N, Machida K, Kurata H, Thant AA, Senga T, Matsuda S, Kimata K, Iwata H, Hamaguchi M. 2001. Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner. Mol Biol Cell 12:1859-68.
27. Solis MA, Chen Y-H, Wong TY, Bittencourt VZ, Lin Y-C, Huang LLH. 2012. Hyaluronan regulates cell behavior: a potential niche matrix for stem cells. Biochem Res Intl 2012: 346972.
28. Tashiro T, Seino S, Sato T, Matsuoka R, Masuda Y, Fukui N. 2012. Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis: a double-blind, placebo-controlled study over a 12-month period. Sci World J 2012:167928.
29. Toole BP, Slomiany MG. 2009. Hyaluronan: a constitutive regulator of chemoresistance and alignancy in cancer cells. Semin Cancer Biol 8:244-50.
30. Uchino K, Takeshita F, Takahashi RU, Kosaka N, Fujiwara K, Naruoka H, Sonoke S, Yano J, Sasaki H, Nozawa S, Yoshiike M, Kitajima K, Chikaraishi T, Ochiya T. 2013. Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression. Mol Ther 21:610-9.
31. Urakawa H, Nishida Y, Knudson W, Knudson CB, Arai E, Kozawa E, Futamura N, Wasa J, Ishiguro N. 2012. Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer. J Orthop Res 30:662-72.
32. Wang YZ, Cao ML, Liu YW, He YQ, Yang CX, Gao F. 2011. CD44 mediates oligosaccharides of hyaluronan-induced proliferation, tube formation and signal transduction in endothelial cells. Exp Biol Med 236:84-90.
33. Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, Matsunaga J, Takahashi R-U, Takata T, Shimamoto A, Ochiya T, Tahara H. 2011. miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol 193:409-24.
34. Zeng C, Toole BP, Kinney SD, Kuo JW, Stamenkovic I. 1998. Inhibition of tumor growth in vivo by hyaluronan oligomers. Intl J Cancer 77:396-401.
35. Zhang Y, Thant AA, Machida K, Ichigotani Y, Naito Y, Hiraiwa Y, Senga T, Sohara Y, Matsuda S, Hamaguchi M. 2002. Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. Cancer Res 62:3962-5.